The center at NJII provides an opportunity for teams to utilize dedicated and experienced teams and state-of-the-art equipment to develop cutting-edge autologous and allogeneic cell therapy products in a cost- and time-effective manner.
A Growing Market
The global market for cell therapy products derived from stem cells, tissues and organs grown in laboratories and transferred back into patients to stop the progression of a multitude of diseases and disorders, is growing at a compounded annual growth rate of more than 23%. As of the end of 2019 there were more than 8,000 active or actively recruiting clinical trials for cell therapies.
In the accelerating race to improve products and gain FDA approval, organizations with promising therapies can benefit greatly from an industry-agnostic platform that offers a variety of resources and services.
We offer two GMP suites to provide you with the capability of preparing for clinical trials without having to take the financial risk and extended timeline to build a new facility from square one.
The Process Development lab is equipped with state-of-the-art cell therapy processing technologies and is capable of developing processes from bench scale to clinical production.
Our goal is to help you augment your in-house process development capacities so you can bring a greater number of projects from preclinical to human trials without risking capital investment or the need to hire additional employees.